Mandate

Vinge advises EQT VI on acquisition of Atos Medical

July 22, 2011

Vinge is advising funds managed by EQT VI Limited in connection with the acquisition of Atos Medical from funds managed by Nordic Capital V Limited (94.6%) and board directors and employees (5.4%). Atos supplies products to the ear, nose and throat (“ENT”) medical segment and is the market leader in voice prosthesis. The acquisition is subject to customary conditions.

The Vinge team included partners Christina Kokko and Johan Göthberg and associates Malin Helgesen, Peter Sundgren, Paul Dali and Anna-Sofia Nilsson Prevell (M&A), partner Maria-Pia Hope and associates Albert Wållgren and Andreas Malmberg (banking & finance), and partner Marcus Glader and associate Peter Alstergren (EU & competition).

Related

Vinge advises The Qt Company Ltd on its public offer for I.A.R. Systems Group AB (publ)

The Qt Company Ltd (“The Qt Company”), a wholly owned subsidiary of Qt Group Plc, has announced a public tender offer to the shareholders of I.A.R. Systems Group AB (publ) (“IAR”) to tender all class B shares in IAR to The Qt Company at a price of SEK 180 in cash per share
July 04, 2025

Vinge has advised Consolid on the establishment of Consolid Equity III

The fund held its final closing on June 2, 2025, having secured commitments from a diverse investor base that includes several leading institutional investors from Europe and North America, as well as established fund-of-funds. The fundraising was highly successful, with the fund significantly oversubscribed. Consolid Equity III has more than doubled its total commitments compared to its predecessor fund.
July 02, 2025

Vinge advises EQT VIII in connection with the divestment of Recover to Pangea AS

Recover is a leading Scandinavian property remediation specialist. Following EQT’s acquisition in 2020, Recover has invested in its digital capabilities while divesting non-core business units to sharpen focus on water, fire and other core property remediation services.
July 02, 2025